Figure 1From: Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study(A) Scattergram of baseline and three-month levels of sHLA-II. The correlation is significant, ρ = .51, p = 0.035. (B) Scattergram of baseline and six-month levels of sHLA-II. The correlation is not significant, ρ = .063, p = 0.81.Back to article page